Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zaleplon for Sleep Quality and Daytime Function in Insomnia
ChiCTR2400087469Phase 4Not yet recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zaleplon in Insomnia, sponsored by Zhongda Hospital, Southeast University. Primary endpoints: Subjective degree of sleep disorders, Daytime emotions and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
zaleplon
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2400087469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087469.